| 論文・執筆名 | 著者 | 共同発表者名 | 論文・書籍名等 | 出版社名等 | 発行年 | 号数等 | 巻号頁 |
|---|---|---|---|---|---|---|---|
| The clinical impact of MRI screening for BRCA mutation carriers: the first report in Japan. | Murakami W | Tozaki M, Nakamura S, Ide Y, Inuzuka M, Hirota Y, Murakami K, Takahama N, Ohgiya Y, Gokan T. | Breast Cancer | Springer | 2019 | [Epub ahead of print] | [Epub ahead of print] |
診療部
論文 診療部－2018年
| 論文・執筆名 | 著者 | 共同発表者名 | 論文・書籍名等 | 出版社名等 | 発行年 | 号数等 | 巻号頁 |
|---|---|---|---|---|---|---|---|
| Simultaneous whole‑body and breast 18F‑FDG PET/MRI examinations in patients with breast cancer: a comparison of apparent diffusion coefficients and maximum standardized uptake values | Michiro Sasaki | Mitsuhiro Tozaki, Kazunori Kubota, Wakana Murakami, Daisuke Yotsumoto, Yasuaki Sagara, Yasuyo Ohi, Shunichi Oosako, Yoshiaki Sagara. | Japanese Journal of Radiology | Springer | 2018 | 36(2) | 122-133 |
| Hybrid PET/MR Imaging of Breast Cancer: Advantages and Pitfalls | K. Kubota | M. Sasaki, M. Tozaki, Y.Sagara. | EPOS | European Society of Radiology | 2018 | Publis hed online | |
| Breast MRI as a Problemsolving Study in the Evaluation of BI-RADS Categories 3 and 4 Microcalcifications: Is it Worth Performing | Shimauchi A | Machida Y, Maeda I, Fukuma E, Hoshi K, Tozaki M. | Academic radiology | Springer | 2018 | 25(3) | 288-296 |
| Randomized phase II study of anastrozole plus tegafur uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC) | Takahiro Nakayama | Yasuaki Sagara, Tsutomu Takashima, Nobuki Matsunami, Norikazu Masuda, Yasuo Miyoshi, Tetsuya Taguchi, Toyokazu Aono, Toshikazu Ito, Tatsuo Kagimura, Shinzaburo Noguchi | Cancer Chemotherapy and Pharmacology | Springer | 2018 | 81(4) | 755-762 |
| Bi‑weekly eribulin therapy for metastatic breast cancer: a multicenter phase II prospective study (JUST‑STUDY) | Shoichiro Ohtani | Takahiro Nakayama, Tetsuhiro Yoshinami, Ken‑ichi Watanabe, Fumikata Hara, Yasuaki Sagara, Hidetoshi Kawaguchi, Kenji Higaki, Nobuki Matsunami, Yoshie Hasegawa, Masato Takahashi, Makiko Mizutani, Takashi Morimoto, Masako Sato, Mitsuya Itoh, Satoshi Morita, Norikazu Masuda | Breast Cancer | Springer | 2018 | 25(4) | 438-446 |
| PCP4/PEP19 upregulates aromatase gene expression via CYP19A1 promoter I.1 in human breast cancer SK-BR-3 cells. | Kie Honjo | Taiji Hamada, Takuya Yoshimura, Seiya Yokoyama, Sohsuke Yamada, Yan-Qin Tan, Lai K. Leung, Norifumi Nakamura, Yasuyo Ohi, Michiyo Higashi, Akihide Tanimoto | Oncotarget | Impact journals | 2018 | 9(51) | 29619-29633 |
| Survival Outcomes of Retreatment with Trastuzumab and Cytotoxic Chemotherapy for HER2-Positive Recurrent Patients With Breast Cancer Who Had Been Treated with Neo/adjuvant Trastuzumab Plus Multidrug Chemotherapy: A Japanese Multicenter Observational Study. | Yamashiro H | Sawaki M, Masuda N, Okumura Y, Takano T, Tokunaga E, Saito T, Sagara Y, Yamazaki K, Kawaguchi Y, Lee T, Ozaki S, Yamagami K, Yamamoto N, Kuroi K, Suwa H, Ohtani S, Ito T, Yasuno S, Morita S, Ohno S, Toi M. | Breast Cancer: Basic and Clinical Research | Libertas Academica | 2018 | 12 | 117822 341878 6243 |
| Shear Wave Speed of the Lesion in Preoperative Breast Ultrasonography: Association with Disease-free Survival of Patients with Primary Operable Invasive Breast Cancer. | Machida Y | Shimauchi A, Okuma H, Tozaki M, Isobe S, Fukuma E |
Academic Radiology | W.B. Saunders Company | 2018 | 25(8) | 1003-1009 |
| A genome-wide association study identifies three novel genetic markers for response to tamoxifen: A prospective multicenter study. | Onishi H | Udagawa C, Kubo M, Nakamura S, Akashi-Tanaka S, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Momozawa Y, Low SK, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, Shimizu D, Tsugawa K, Shimo A, Hartman M, Chan CW, Lee SC, Endo , Zembutsu H | PLoS One | PLOS | 2018 | 13(8) | e02016 06. |
| Intraoperative Nomograms, Based on One-Step Nucleic Acid Amplification, for Prediction of Non-sentinel Node Metastasis and Four or More Axillary Node Metastases in Breast Cancer Patients with Sentinel Node Metastasis. | Shimazu K | Sato N, Ogiya A, Sota Y, Yotsumoto D, Ishikawa T, Nakamura S, Kinoshita T, Tsuda H, Ohi Y, Akiyama F, Noguchi S. | Annals of surgical oncology | Springer | 2018 | 25(9) | 2603-2611 |
| Effectiveness of neo-adjuvant systemic therapy with trastuzumab for basal HER2 type breast cancer: results from retrospective cohort study of Japan Breast Cancer Research Group (JBCRG)-C03. | Yasuaki Sagara | Masahiro Takada, Yasuyo Ohi, Shoichiro Ohtani, Sasagu Kurozumi, Kenichi Inoue, Yoshimasa Kosaka, Masaya Hattori, Toshinari Yamashita, Shintaro Takao, Nobuaki Sato, Hiroji Iwata, Masafumi Kurosumi, Masakazu Toi | Breast Cancer Research and Treatment | Springer | 2018 | 171(3) | 675-683 |
| Does integrated shimming improve lesion detection in whole-body diffusion-weighted examinations of patients with breast cancer? | Sasaki M | Tozaki M, Maruyama K, Benkert T, Murakami W, Yotsumoto D, Oosako S, Sagara Y | Japanese Journal of Radiology | Springer | 2018 | 36(12) | 736-743 |
| Maspin mRNA expression in sentinel lymph nodes predicts non-SLN metastasis in breast cancer patients with SLN metastasis. | Umekita Y | Ohi Y, Iwaya O, Souda M, Sagara Y, Tamada S, Yotsumoto D, Tanimoto A | Histopathology | John Wiley & Sons | 2018 | 73(6) | 916-922 |
| Apocrine papillary lesion: comparison of pathological findings from 22 years previously and the present. | Yuki Nomoto | Heiji Yoshinaka, Yasuyo Ohi, Naoki Hayashi, Ayako Nagata, Kazunobu Sueyoshi, Yuka Eguchi, Yoshiaki Shinden, Yuko Kijima, Shoji Natsugoe | Breast Cancer | Springer | 2018 | [Epub ahead of print] | [Epub ahead of print] |
| Validation of the 21-gene test as a predictor of clinical response to neoadjuvant hormonal therapy for ER+, HER2-negative breast cancer: the TransNEOS study. | Iwata H | Masuda N, Yamamoto Y, Fujisawa T, Toyama T, Kashiwaba M, Ohtani S, Taira N, Sakai T, Hasegawa Y, Nakamura R, Akabane H, Shibahara Y, Sasano H, Yamaguchi T, Sakamaki K, Bailey H, Cherbavaz DB, Jakubowski DM, Sugiyama N, Chao C, Ohashi Y. | Breast Cancer Research and Treatment | Springer | 2018 | 173 | 123-133 |
| Impact of Topoisomerase IIα, PTEN, ABCC1/MRP1, and KI67 on triple-negative breast cancer patients treated with neoadjuvant chemotherapy. | Guestini F | Ono K, Miyashita M, Ishida T, Ohuchi N, Nakagawa S, Hirakawa H, Tamaki K, Ohi Y, Rai Y, Sagara Y, Sasano H, McNamara KM | Breast Cancer Research and Treatment | Springer | 2018 | 173(2) | 275-288 |
| Effects of menstrual cycle on background parenchymal enhancement and detectability of breast cancer on dynamic contrast-enhanced breast MRI: A multicenter study of an Asian population. | Kamitani T | Yabuuchi H, Kanemaki Y, Tozaki M, Sonomura T, Mizukoshi W, Nakata W, Shimono T, Urano M, Yamano T, Kato F, Kuchiki M, Shiraga N, Yanagita H, Katsuda E, Kataoka M, Yamaguchi K, Horikoshi T, Gomi T, Nozaki M, Shiotani M, Amano M, Saigusa H, Sadaoka S, Kamiya H, Kubo M, Yamashita N, Yamamoto H, Honda H. | European journal of radiology | ELESEVIER | 2018 | 110 | 130-135 |
論文 診療部－2017年
| 論文・執筆名 | 著者 | 共同発表者名 | 論文・書籍名等 | 出版社名等 | 発行年 | 号数等 | 巻号頁 |
|---|---|---|---|---|---|---|---|
| Role of HER2-Related Biomarkers (HER2, p95HER2, HER3, PTEN, and PIK3CA) in the Efficacy of Lapatinib plus Capecitabine in HER2-Positive Advanced Breast Cancer Refractory to Trastuzumab. | Nishimura R | Toh U, Tanaka M, Saimura M, Okumura Y, Saito T, Tanaka T, Teraoka M, Shimada K, Katayama K, Koga T, Kurashita K, Hasegawa S, Todoroki H, Kai Y, Ohi Y, Toyoshima S, Arima N, Mitsuyama S, Tamura K. | Oncology | KARGER | 2017 | 93(1) | 51-61 |
| The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy | Tanaka K | Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y. | Breast Cancer | Springer | 2017 | 24(3) | 384-392 |
| Breast cancer prevention strategies in lobular carcinoma in situ: A decision analysis. | Wong SM | Stout NK, Punglia RS, Prakash I, Sagara Y, Golshan M. | Cancer | Wiley | 2017 | 123(14) | 2609-2617 |
| Effects of cytokines derived from cancer-associated fibroblasts on androgen synthetic enzymes in estrogen receptor-negative breast carcinoma | Kikuchi K | McNamara KM, Miki Y, Moon JY, Choi MH, Omata F, Sakurai M, Onodera Y, Rai Y, Ohi Y, Sagara Y, Miyashita M, Ishida T, Ohuchi N, Sasano H. | Breast Cancer Research and Treatment | Springer | 2017 | 166(3) | 709-723 |
| Paradigm Shift toward Reducing Overtreatment of Ductal Carcinoma In Situ of Breast | Sagara Y | Julia W, Golshan M, Toi M. | Frontiers in Oncology | Frontiers Media SA | 2017 | Publis hed online | |
| Trends in adjuvant therapies after breast-conserving surgery for hormone receptorpositive ductal carcinoma in situ : findings from the National Cancer Database, 2004-2013 | Yasuaki Sagara | Rachel A. Freedman, Stephanie M. Wong, Faitih Aydogan, Anvy Nguyen, William T.Barry, Mehra Golshan. | Breast Cancer Research and Treatment | Springer | 2017 | 166(2) | 583-592 |
論文 診療部－2016年
| 論文・執筆名 | 発表者名 | 共同発表者名 | 論文・書籍名等 | 出版社名等 | 発行年 | 号数等 | 掲載ページ |
|---|---|---|---|---|---|---|---|
| Tumor microenvironment in invasive lobular carcinoma: possible therapeutic targets. | Nakagawa S | Miki Y, Miyashita M, Hata S, Takahashi Y, Rai Y, Sagara Y, Ohi Y, Hirakawa H, Tamaki K, Ishida T, Watanabe M, Suzuki T, Ohuchi N, Sasano H. | Breast Cancer Research and Treatment | Springer | 2016 | 155(1) | 65-75 |
| Morphology evaluation of nonmass enhancement on breast MRI: Effect of a three-step interpretation model for readers’ performances and biopsy recommendations. | Akiko Shimauchi | Hideki Ota, Youichi Machida, Tamiko Yoshida, Nozomi Satani, Naoko Mori, Kei Takase, Mitsuhiro Tozaki | European Journal of Radiology | ELSEVIER | 2016 | 85(2) | 480–488 |
| Assessment of the Ki67 labeling index: a Japanese validation ring study | Niikura N | Sakatani T, Arima N, Ohi Y, Honma N, Kanomata N, Yoshida K, Kadoya T, Tamaki K, Kumaki N, Iwamoto T, Sugie T, Moriya T. | Breast Cancer | Springer | 2016 | 23(1) | 92-100 |
| Patient Prognostic Score and Associations With Survival Improvement Offered by Radiotherapy After Breast-Conserving Surgery for Ductal Carcinoma In Situ: A Population-Based Longitudinal Cohort Study | Yasuaki Sagara | Rachel A. Freedman, Ines Vaz-Luis, Melissa Anne Mallory, Stephanie M. Wong, Fatih Aydogan, Stephen DeSantis, William T. Barry and Mehra Golshan. | Journal of Clinical Oncology | ASCO | 2016 | 34(11) | 1190-1196 |
| Intratumoral estrogen production and actions in luminal A type invasive lobular and ductal carcinomas. | Takagi M | Miki Y, Miyashita M, Hata S, Yoda T, Hirakawa H, Sagara Y, Rai Y, Ohi Y, Tamaki K, Ishida T, Suzuki T, Ouchi N, Sasano H. | Breast Cancer Res Treat | Springer | 2016 | 156(1) | 45-55 |
| Growing Use of Contralateral Prophylactic Mastectomy Despite no Improvement in Long-term Survival for Invasive Breast Cancer. | Wong SM | Freedman RA, Sagara Y, Aydogan F, Barry WT, Golshan M. | Annals of Surgery | LIPPINCOTT WILLIAMS & WILKINS | 2016 | 2017.3.8 | [Epub ahead of print] |
| The Japanese Breast Cancer Society clinical practice guidelines for screening and imaging diagnosis of breast cancer, 2015 edition | Tozaki M | Kuroki Y, Kikuchi M, Kojima Y, Kubota K, Nakahara H, Ito Y, Mukai H. | Breast Cancer | Springer | 2016 | 23(3) | 357-366 |
| Prognostic and predictive impacts of tumor-infiltrating lymphocytes differ between Triple-negative and HER2-positive breast cancers treated with standard systemic therapies | Hida AI | Sagara Y, Yotsumoto D, Kanemitsu S, Kawano J, Baba S, Rai Y, Oshiro Y, Aogi K, Sagara Y, Ohi Y. | Breast Cancer Res Treat | Springer | 2016 | 158(1) | 1-9 |
| Descriptors of Malignant Non-mass Enhancement of Breast MRI:: Their Correlation to the Presence of Invasion. | Machida Y | Shimauchi A, Tozaki M, Kuroki Y, Yoshida T, Fukuma E. | Acad Radiol | ELSEVIER | 2016 | 23(6) | 687-695 |
| The relationship between the expression of FOXA1 and GATA3 and the efficacy of neoadjuvant endocrine therapy. | Tanaka K | Tokunaga E, Yamashita N, Sagara Y, Ohi Y, Taguchi K, Ohno S, Okano S, Oda Y, Maehara Y. | Breast Cancer | Springer | 2016 | [Epub ahead of print] | |
| Single focus on breast magnetic resonance imaging: diagnosis based on kinetic pattern and patient age | Machida Y | Shimauchi A, Kuroki Y, Tozaki M, Kato Y, Hoshi K, Fukuma E. | Acta Radiol | SAGE | 2016 | 23 | [Epub ahead of print] |
| Reply to K. Lin et al. | Sagara Y | Freedman RA, Mallory MA, Wong SM, Barry WT, Golshan M. | Journal of Clinical Oncology | ASCO | 2016 | 34(28) | 3485-3486 |
| Significant Effect of Polymorphisms in CYP2D6 on Response to Tamoxifen Therapy for Breast Cancer; a Prospective Multicenter Study. | Zembutsu H | Nakamura S, Akashi ST, Kuwayama T, Watanabe C, Takamaru T, Takei H, Ishikawa T, Miyahara K, Matsumoto H, Hasegawa Y, Kutomi G, Shima H, Satomi F, Okazaki M, Zaha H, Onomura M, Matsukata A, Sagara Y, Baba S, Yamada A, Shimada K, et al. | Clinical Cancer Research | AACR | 2016 | [Epub ahead of print] | |
| 乳癌センチネルリンパ節転移径と4個以上のリンパ節転移の関連についての検討 | 四元大輔 | 相良安昭、大井恭代、佐藤睦、松方絢美、川野純子、寺岡恵、木谷哲、金光秀一、馬場信一、相良吉昭、松山義人、安藤充嶽、相良吉厚、雷哲明 | 乳癌の臨床 | 篠原出版新社 | 2016 | 31(2) | 107(33)-113(39) |
| 第5回全国集計結果報告 | 吉田雅行 | 笠原善郎、辻一郎、大貫幸二、鯉淵幸生、坂佳奈子、古川順康、増岡秀次、村田陽子、森田孝子、山川卓、雷哲明 | 日本乳癌学会学術誌 | 日本乳癌学会 | 2016 | 25(1) | 31-42 |
| これまでの全国集計データの分析と未把握率からみた精度管理指標の提案 | 笠原善郎 | 大貫幸二、辻一郎、鯉淵幸生、坂佳奈子、古川順康、増岡秀次、村田陽子、森田孝子、山川卓、吉田雅行、雷哲明 | 日本乳癌検診学会誌 | 日本乳癌検診学会 | 2016 | 25(1) | 51-56 |
論文 診療部－2015年
| 論文・執筆名 | 発表者名 | 共同発表者名 | 論文・書籍名等 | 出版社名等 | 発行年 | 号数等 | 掲載ページ |
|---|---|---|---|---|---|---|---|
| The Japanese Breast Cancer Society Clinical Practice Guideline for systemic treatment of breast cancer. | Hirofumi Mukai | Tomohiko Aihara, Yutaka Yamamoto, Masato Takahashi, Tatsuya Toyama, Yasuaki Sagara, Hiroshi Yamaguchi, Hiromitsu Akabane, Junji Tsurutani,Fumikata Hara, Tomomi Fujisawa, Naohito Yamamoto, Shozo Ohsumi | Breast Cancer | Springer | 2015 | 22(1) | 5-15 |
| Surgical Options and Locoregional Recurrence in Patients Diagnosed with Invasive Lobular Carcinoma of the Breast |
Yasuaki Sagara | William T. Barry, Melissa Anne Mallory, Ines Vaz-Luis, Fatih Aydogan, Jane E. Brock, Eric P. Winer, Mehra Golshan, and Otto Metzger-Filho | Annals of Surgical Oncology | Springer | 2015 | ||
| An international study to increase concordance in Ki67 scoring. | Polley MY | Leung SC, Gao D, Mastropasqua MG, Zabaglo LA, Bartlett JM, McShane LM, Enos RA, Badve SS, Bane AL, Borgquist S, Fineberg S, Lin MG, Gown AM, Grabau D, Gutierrez C, Hugh JC, Moriya T, Ohi Y, Osborne CK, Penault-Llorca FM, Piper T, Porter PL, Sakatani T, Salgado R, Starczynski J, Lænkholm AV, Viale G, Dowsett M, Hayes DF, Nielsen TO | Modern Pathology | PubMed | 2015 | ||
| Survival Benefit of Breast Surgery for Low-Grade Ductal Carcinoma In Situ: A Population-Based Cohort Study. | Yasuaki Sagara | Mallory MA, Wong S, Aydogan F, DeSantis S, Barry WT, Golshan M. | JAMA Surger | JAMA | 2015 Aug | 150(8) | 150(8):739-45 |
| Immediate breast volume replacement using a free dermal fat graft after breast cancer surgery: multi-institutional joint research of short-term outcomes in 262 Japanese patients | Yuko Kijima | Chihaya Koriyama, Teruhiko Fujii, Kouichi Hirokaga, Kiyoshi Ishigure, Tomoyo Kaneko, Shuji Kayano, Sachio Miyamoto, Yasuaki Sagara, Takashi Sakurai, Teruhisa Sakurai, Keiichi Sotome, Hiroaki Ueo, Kazuyuki Wakita, Masahiro Watatani | GLAND SURGERY | journal | 2015 Apr | 4(2) | 4(2):179-94 |
| Phase III placebo-controlled, double-blind, randomized trial of pegfilgrastim to reduce the risk of febrile neutropenia in breast cancer patients receiving docetaxel/cyclophosphamide chemotherapy. | Kosaka Y | Y, Rai Y, Masuda N, Takano T, Saeki T, Nakamura S, Shimazaki R, Ito Y, Tokuda Y, Tamura K. | Support Care Cancer | Springer | 2015 Apr | 23(4) | 23(4):1137-43 |
| Two Distinct Types of Linear Distribution in Nonmass Enhancement at Breast MR Imaging: Difference in Positive Predictive Value between Linear and Branching Patterns. | Machida Y | Tozaki M, Shimauchi A, Yoshida T | Radiology | RADIOLOGICAL SOC.OF N.A. | 2015 Sep | 276(3):686-94 | |
| Prevalence and differentiation of hereditary breast and ovarian cancers in Japan. | Nakamura S | Takahashi M, Tozaki M, Nakayama T, Nomizu T, Miki Y, Murakami Y, Aoki D, Iwase T, Nishimura S, Yamauchi H, Ohsumi S, Baba S, Shimizu T. | Breast Cancer | 日本乳癌学会 | 2015 Sep | 22(5):462-8 | |
| A low cost training phantom model for radio-guided localization techniques in occult breast lesions. | Aydogan F | Mallory MA, Tukenmez M, Sagara Y, Ozturk E, Ince Y, Celik V, Akca T, Golshan M. | Journal of Surgical Oncology | 2015 Sep | 112(4):449-51 | ||
| The Influence of Radiology Image Consultation in the Surgical Management of Breast Cancer Patients. | Mallory MA | Losk K, Lin NU, Sagara Y, Birdwell RL, Cutone L, Camuso K, Bunnell C, Aydogan F, Golshan M. | Annals of Surgical Oncology | Springer | 2015 Oct | 22(10) | 22(10):3383-8 |
| Modern Trends in the Surgical Management of Paget’s Disease. | Wong SM | Freedman RA, Stamell E, Sagara Y, Brock JE, Desantis SD, Golshan M. | Annals of Surgical Oncology | Springer | 2015 Oct | 22(10) | 22(10):3308-16 |
| Positive predictive value for malignancy of pure flat epithelial atypia diagnosis by percutaneous needle biopsy of the breast: management of FEA in ultrasonography. | Maeda I | Kanemaki Y, Tozaki M, Koizumi H, Oana Y, Okanami Y, Tsuchiya K, Shimo A, Kojima Y, Hayami R, Nishikawa T, Kawamoto H, Yabuki Y, Tsugawa K, Takagi M | Breast Cancer | 日本乳癌学会 | 2015 Nov | 22(6):634-40 | |
| The effect of Paget disease on axillary lymph node metastases and survival in invasive ductal carcinoma. | Wong SM | Freedman RA, Sagara Y, Stamell EF, Desantis SD, Barry WT, Golshan M. | Cancer | Wiley | 2015 Dec | 121(24) | 121(24):4333-40 |